---
schema_version: "secwatch.filing_event.v1"
accession: "0001522767-23-000100"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2023-08-02T23:59:59+00:00"
generated_at: "2026-06-12T13:08:07.734398+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MariMed Q2 revenue $36.5M (+11% YoY); GAAP net loss $0.9M vs $1.9M profit

## Summary
- Revenue $36.5M, up 11% from $33.0M year-over-year; wholesale set monthly and quarterly records.
- GAAP net loss $0.9M vs income $1.9M in Q2 2022; non-GAAP net income $0.6M vs $5.5M.
- Adjusted EBITDA $6.3M (17% margin) down from $8.9M (27% margin) last year; 14th straight positive quarter.
- Non-GAAP gross margin 46% flat YoY; balance sheet remains one of strongest in industry.
- Adult-use sales in Maryland commenced July 1, 2023, driving expected acceleration.

## SEC filing metadata
- accession: 0001522767-23-000100
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2023-08-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000100/0001522767-23-000100-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000100/mrmd-20230802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001522767-23-000100
- JSON: https://secwatch.observer/filing/0001522767-23-000100.json
- Plain text: https://secwatch.observer/filing/0001522767-23-000100.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.